These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4343934)
21. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Mahon BP; Ryan MS; Griffin F; Mills KH Infect Immun; 1996 Dec; 64(12):5295-301. PubMed ID: 8945580 [TBL] [Abstract][Full Text] [Related]
22. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound]. Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575 [No Abstract] [Full Text] [Related]
23. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Komatsu E; Yamaguchi F; Eguchi M; Watanabe M Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876 [TBL] [Abstract][Full Text] [Related]
24. Relationship of increased histidine decarboxylase activity to Bordetella pertussis vaccine sensitization of mice. SCHAYER RW; GANLEY OH J Allergy; 1961; 32():204-13. PubMed ID: 13747330 [No Abstract] [Full Text] [Related]
25. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis. Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261 [TBL] [Abstract][Full Text] [Related]
26. [Protective effects of human gamma globulin preparations against experimental aerosol infections of mice with Bordetella pertussis]. Imaizumi A; Suzuki Y; Sato Y Kansenshogaku Zasshi; 1984 Jun; 58(6):518-24. PubMed ID: 6092492 [No Abstract] [Full Text] [Related]
27. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713 [TBL] [Abstract][Full Text] [Related]
28. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate. Cornford-Nairns R; Daggard G; Mukkur T J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165 [TBL] [Abstract][Full Text] [Related]
29. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566 [TBL] [Abstract][Full Text] [Related]
33. Antibody Specificity Following a Recent Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T Front Immunol; 2019; 10():1364. PubMed ID: 31275314 [No Abstract] [Full Text] [Related]
34. The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis. Standfast AF; Dolby JM J Hyg (Lond); 1972 Sep; 70(3):487-501. PubMed ID: 4341998 [TBL] [Abstract][Full Text] [Related]
35. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice. Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638 [No Abstract] [Full Text] [Related]
37. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Pittman M Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166 [TBL] [Abstract][Full Text] [Related]
38. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization. Kanojia G; Raeven RHM; van der Maas L; Bindels THE; van Riet E; Metz B; Soema PC; Ten Have R; Frijlink HW; Amorij JP; Kersten GFA J Control Release; 2018 Sep; 286():167-178. PubMed ID: 30048656 [TBL] [Abstract][Full Text] [Related]
39. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis. Mills KH; Gerdts V J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866 [TBL] [Abstract][Full Text] [Related]